LAG3 and cancer: Immune checkpoint receptors, including CTLA-4, PD-1, PD-L1, and LAG-3 (Lymphocyte activation gene 3), are inhibitory molecules present on the surface of immune cells, cancer cells and other supporting cells in the TME [29].